Tenon Medical Files 8-K Amendment
Ticker: TNONW · Form: 8-K/A · Filed: Oct 17, 2025 · CIK: 1560293
| Field | Detail |
|---|---|
| Company | Tenon Medical, Inc. (TNONW) |
| Form Type | 8-K/A |
| Filed Date | Oct 17, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, financial-statements, exhibits
Related Tickers: TNON
TL;DR
Tenon Medical filed an 8-K amendment on Aug 1st, likely updating financials.
AI Summary
Tenon Medical, Inc. filed an amendment (Amendment #1) to its Form 8-K on October 17, 2025, reporting events that occurred on August 1, 2025. The filing primarily concerns financial statements and exhibits, indicating a potential update or correction to previously reported information.
Why It Matters
This amendment suggests Tenon Medical is providing updated or corrected financial information, which could impact investor understanding of the company's financial health.
Risk Assessment
Risk Level: medium — Amendments to 8-K filings often indicate a need to correct or supplement previous disclosures, which can introduce uncertainty.
Key Players & Entities
- Tenon Medical, Inc. (company) — Registrant
- August 1, 2025 (date) — Earliest event reported
- October 17, 2025 (date) — Filing date
- 001-41364 (other) — SEC File Number
- 45-5574718 (other) — IRS Employer Identification No.
FAQ
What specific financial statements or exhibits are being amended by Tenon Medical, Inc.?
The filing states that the amendment concerns 'Financial Statements and Exhibits' but does not specify which ones in the provided text.
What was the original event date that this 8-K/A filing is amending?
The earliest event reported in this amendment was on August 1, 2025.
When was this amendment filed with the SEC?
This amendment was filed as of October 17, 2025.
What is Tenon Medical, Inc.'s principal executive office address?
The principal executive offices are located at 104 Cooper Court, Los Gatos, CA 95032.
What is the SIC code for Tenon Medical, Inc.?
The Standard Industrial Classification code for Tenon Medical, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
Filing Stats: 729 words · 3 min read · ~2 pages · Grade level 10.6 · Accepted 2025-10-17 17:15:27
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share TNON The Nasdaq Stock Mar
Filing Documents
- ea0261583-8ka1_tenon.htm (8-K/A) — 32KB
- ea026158301ex99-1_tenon.htm (EX-99.1) — 224KB
- ea026158301ex99-2_tenon.htm (EX-99.2) — 92KB
- 0001213900-25-100037.txt ( ) — 594KB
- tnon-20250801.xsd (EX-101.SCH) — 4KB
- tnon-20250801_def.xml (EX-101.DEF) — 26KB
- tnon-20250801_lab.xml (EX-101.LAB) — 36KB
- tnon-20250801_pre.xml (EX-101.PRE) — 25KB
- ea0261583-8ka1_tenon_htm.xml (XML) — 6KB
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (a) Financial statements of businesses acquired
Financial statements of SiVantage, Inc. for the year ended December
Financial statements of SiVantage, Inc. for the year ended December 31, 2024 and for the six months ended June 30, 2025, and the notes related thereto, are attached hereto as Exhibit 99.1 and incorporated herein by reference into this Item 9.01(a). (b) Pro forma financial information. The following unaudited pro forma condensed combined financial information of the Company attached hereto as Exhibit 99.2 and incorporated herein by reference into this Item 9.01(b). Unaudited pro forma condensed balance sheet as of June 30, 2025; Unaudited pro forma condensed statement of operations for the year ended December 31, 2024; and Unaudited pro forma condensed statement of operations for the six months ended June 30, 2025. (d) Exhibits The following exhibits are filed herewith: Exhibit No. Description 99.1 Audited financial statements of SiVantage, Inc. for the year ended December 31, 2024, and the notes related thereto, and unaudited financial statements of SiVantage, Inc. for the six month period ended June 30, 2025, and the notes related thereto. 99.2 Unaudited pro forma condensed balance sheet as of June 30, 2025, unaudited pro forma condensed statement of operations for the year ended December 31, 2024, and unaudited pro forma condensed statement of operations for the six months ended June 30, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 17, 2025 TENON MEDICAL, INC. (Registrant) By: /s/ Steven M. Foster Name: Steven M. Foster Title: Chief Executive Officer and President 3